Given the GSEA result that low score ER-positive/HER2-negative breast cancers were enriched with immune-related gene set, it was of interest to study the association of the estrogen response score and tumor immune microenvironment (TIME) in ER-positive/HER2-negative breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.